New research published in The Journal of Clinical Investigation argues that Alzheimer’s may begin much earlier than ...

The study analyzed the evolution of white matter hyperintensities (WMH), lesions typically associated with cerebral vascular ...

NHS watchdog to review evidence on two pioneering Alzheimer’s drugs - Donanemab and lecanemab were licensed for use in the UK in 2024 but were not made available on the NHS after Nice deemed their ben ...

What has long been interpreted as permanent and irreversible vascular damage may not be exclusively so. In people with Down syndrome—one of the most robust populations for studying Alzheimer's disease ...

Black Americans are nearly twice as likely as their white counterparts to develop dementia, and researchers have found that obesity may be a significant factor in accelerating cognitive decline, ...

Alzheimer’s disease affects millions of people around the world and is one of the leading causes of memory loss and cognitive ...

Smith Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory ...

A new Duke study is exploring whether cells inside the nose could reveal early signs of Alzheimer’s disease. Researchers say ...

After decades of slow progress in understanding and developing effective treatments for Alzheimer’s disease, scientists are ...

Families can help loved ones live well after a dementia diagnosis by planning early, creating a safe environment, staying engaged in meaningful activities, and building a strong support network ...

Researchers say a simple blood test could help flag which older women face a higher risk of dementia long before any symptoms ...

"Advances in biomarker technology, digital cognitive assessments, and amyloid-targeting therapies have redefined the opportunities for accurate and early diagnosis and care of Alzheimer's disease," ...